Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
3(60.0%)
N/A
2(40.0%)
5Total
Phase 2(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05978882Not ApplicableNot Yet Recruiting

Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)

Role: collaborator

NCT01825824Phase 2Unknown

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm

Role: collaborator

NCT01850667Phase 2Completed

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Role: collaborator

NCT01850368Phase 2Completed

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

Role: collaborator

NCT03024151Not ApplicableCompleted

The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients

Role: collaborator

All 5 trials loaded